Results 101 to 110 of about 202,126 (199)

No-reflow phenomenon

Cardiology Journal, 2012
Jeffrey D, Nadelson, Mladen I, Vidovich
openaire   +2 more sources

Incidence of the no-reflow phenomenon and its reversal in patients with central retinal artery occlusion (CRAO).

, 2015
The no-reflow phenomenon was defined as the lack of tissue (capillary) reperfusion after successful arterial recanalization in this study. Among the 102 enrolled patients whose arterial recanalization was confirmed by fluorescein angiography (FA) images,
Na-Kyung Ryoo (829551), Cheolkyu Jung (829552), Moon-Ku Han (396939), Seong Joon Ahn (576995), Chang-Hwan Yoon (396937), Se Joon Woo (484361), Kyu Hyung Park (43972), Jeong-Ho Hong (540747)   +7 more
core   +1 more source

Assessment of “microvascular no-reflow phenomenon” using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction

, 1998
Objectives. The aim of this study was the scintigraphic evaluation of clinical no-reflow phenomenon.Background. In patients with acute myocardial infarction, the relationship of the severity of reduction of microvascular reflow to the ischemia time or to
Yukio Shimono, Nakano, Akira, Shimono, Yukio, Kondo, Makoto, Makoto Kondo, Akira Nakano, Daiki Saito, Saito, Daiki   +7 more
core   +1 more source

[No-reflow phenomenon in the practice of an endovascular surgeon].

Vestnik rentgenologii i radiologii, 2014
No-reflow phenomenon is a complication of percutaneous coronary intervention and is the absence of distal coronary bed filling. The main cause of this phenomenon is distal embolism of the coronary artery by atheromatous and thrombotic masses. The paper gives different classifications for evaluation of myocardial and coronary reperfusion.
A. M. Gerasimov, A. S. Tereshchenko, E. V. Merkulov, A. N. Samko   +3 more
openaire   +2 more sources

Beneficial effect of post-procedural abciximab in patients undergoing primary coronary angioplasty and presenting with the no-reflow phenomenon.

, 2008
We sought to investigate the effect of post-procedural abciximab on clinical outcome of patients presenting the no-reflow phenomenon after primary angioplasty.
PICCHI A, MONDILLO, SERGIO, MARZILLI M., SINICROPI G, MARZILLI, MARIO, ZACA V, PIERLI C, MONDILLO S, CASINI S, BUTI A, FOCARDI M, FINESCHI M   +11 more
core   +1 more source

Effects of streptokinase on reflow in rescue percutaneous coronary intervention

ARYA Atherosclerosis, 2013
BACKGROUND: Primary percutaneous coronary intervention (PPCI) is the preferred treatment method for ST elevation myocardial infarction (STEMI). However, the required equipments are not available in all hospitals.
Masoud Sanatkar, Hassan Shemirani, Hamid Sanei, Masoud Pourmoghaddas, Katayoun Rabiei   +4 more
doaj  

The no-reflow phenomenon: current treatment and prevention strategies

The no-reflow phenomenon remains a significant challenge in the management of myocardial infarction, despite advances in reperfusion therapy, including widespread use of primary percutaneous coronary intervention (PCI).
S. V. Dil, E. V. Vyshlov, M. A. Kercheva, L. N. Maslov, V. V. Ryabov   +4 more
core   +1 more source

The Association Between Atherogenic Index of Plasma and No-Reflow Phenomenon in Acute Coronary Syndrome. [PDF]

Anatol J Cardiol, 2023
Çelik İE, Öztürk S, Yarlıoğlu M, Barutçu O, Akgün O, Duran M, Yorulmaz Ş, Murat SN.   +7 more
europepmc   +1 more source

Hyperglycemia as a predictor for no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction

Clinical Innovations in Health Research-HJM
Introduction: The no-reflow phenomenon (NRP) is a complication associated with in-hospital mortality in patients undergoing percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).
Oswaldo Aldana-Varela, Iván R. Flores-Gómez, Araceli Villanueva-Balandrán, Ricardo J. López-Castellanos, José L. Victoria-Campos, Ma. de Lourdes Santiago-González   +5 more
doaj  

The role of non-coding RNAs in the coronary no-reflow phenomenon: a systematic review. [PDF]

Mol Biol Rep
Sukiennik A, Tomkiel D, Procyk G.
europepmc   +1 more source